Attention-deficit/Hyperactivity Disorder
Conditions
Brief summary
The association between levels of zonulin and occludin and behavioral/emotional problems in children with ADHD are investigated.
Detailed description
Inclusion criteria for the ADHD group are (a) newly diagnosed ADHD (b) no prior psychotropic treatment for ADHD or any psychiatric disorder (c) age 6-12 years. Exclusion criteria were: (a) history of history of inflammatory/noninflammatory, metabolic, or autoimmune disease (b) any special diet history within the past year (c) use of corticosteroids or regular intake of medication in the last 6 months, (d) body mass index (BMI) \[kg/m2\] \> 30), and (e) cognitive deficits by developmental history.
Interventions
Serum zonulin level
Serum occludin level
Sponsors
Study design
Eligibility
Inclusion criteria
* (a) newly diagnosed ADHD * (b) no prior psychotropic treatment for ADHD or any psychiatric disorder * (c) age 6-12 years.
Exclusion criteria
* (a) history of history of inflammatory/noninflammatory, metabolic, or autoimmune disease * (b) any special diet history within the past year * (c) use of corticosteroids or regular intake of medication in the last 6 months, * (d) body mass index (BMI) \[kg/m2\] \> 30), * (e) cognitive deficits by developmental history
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Zonulin level | 1 month | Serum Zonulin level after psychiatric interview |
| Occludin level | 1 month | Serum Occludin level after psychiatric interview |
Countries
Turkey (Türkiye)